Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Netflix faces a pivotal 2026-27 as ad revenue and free cash flow rise. Analysts sketch a path to roughly $300 by 2028...
Qualcomm surged in early trading after landing Meta Platforms as a data center customer for its Dragonfly chip, then ...
As token prices falter, traders are eyeing crypto-linked equities as the potential catalyst for the next crypto recov...
A Huron Consulting Group director recently sold a sizable block of shares in a single open-market trade. This article...
Looking for a single artificial intelligence stock hold to ride AI-era gains for 10 years? This guide explains why Al...
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
Solana (sol) hits 2026 high in headlines as sentiment worsens, yet new on-chain activity and a fresh technical setup ...
A widow turned down survivor benefits at age 60 to wait for a larger payoff, but four years later she faces a $50,000...
A Massachusetts man fell for a phony online romance that morphed into a fake crypto investment. He ended up losing hu...
Insider trades can offer clues about a company’s near-term path. This article digs into a Mineralys insider banked $5...